Delivery Order SPE2DB20D1109-SPE2DB25FN74C
Award Date
3/17/25
Potential Completion Date
4/7/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML. The $33,547.00 firm fixed price contract has an ultimate completion date of December 31, 2024. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,746.22 firm-fixed-price delivery order is for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,243.70 firm fixed-price delivery order is for the procurement of 1,500 units of the 10 ML KEDRAB vaccine vial. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,320.48 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,995.18, is for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract is a Firm Fixed Price Delivery Order with a completion date of March 31, 2025. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,500 units of the drug KEDRAB, a 10 ml vial, with an ultimate completion date of August 28, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,626.70, is for the delivery of 1,500 units of the KEDRAB 10 ML vaccine vial. It is a firm fixed-price delivery order contract with a period of performance through March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,945.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of September 25, 2024. This award does not have a set-aside designation. AmerisourceBergen Drug Corp holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,594.16 Firm Fixed Price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a medical product, with a period of performance ending on March 21, 2024. The contract was awarded on February 29, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...